Web Analytics
Cổ phiếu KLRA (NASDAQ) | KAILERA THERAPEUTICS, INC. COMMON STOCK – Phân tích Deepscope
MARKET

Select Market Data Region

KLRA — KAILERA THERAPEUTICS, INC. COMMON STOCK (Healthcare >> Biotechnology)

KLRA FAQ

What is KLRA's ROE?

KAILERA THERAPEUTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of 22.41%.

What is KLRA's dividend yield?

KAILERA THERAPEUTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.

What is KLRA's Deepscope Quality Score?

Deepscope rates KLRA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy KLRA?

Deepscope's AI Timing Score for KLRA is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does KLRA belong to?

KAILERA THERAPEUTICS, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-05 | FS: 2026-03-31)

KLRA

KAILERA THERAPEUTICS, INC. COMMON STOCK
USD 19.37
-1.62 (-7.72%) Day Change
-2.45
D/E
22.4%
ROE
-15.5%
ROA
0.00%
Div Yield

KAILERA THERAPEUTICS, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare   Watchlist   Myport
USD 19.37
Price
-1.62 (-7.72%)
Day Change
NEWS SCORE: 90

KLRA Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng 41%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.16 From 30 days period
  News Score 90
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 19.37
  PBV / Sector
-6.71 / 4.63
  Earning Per Share -0.65
  PE / Sector
N/A / 17.43
  PEG or PE/Growth / Sector
N/A / 0.53
  Average 1M Daily Value
8.90 M
  Average 1W Daily Value
9.04 M
Yếu tố Kỹ thuật 42%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 37%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 47%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 449.48
  NPM Average (%) / Sector
0.03 / -1,506.49
  NPM Change Average (%) / Sector
N/A / 4,940.99
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-15.50 / 30.58
  ROA Average (%) / Sector
-12.30 / -347.17
  ROA Change Average (%) / Sector
-9,076.77 / 5,125.52
  ROE (%) / Sector
22.41 / -3.58
GOOD
  ROE Average (%) / Sector
21.37 / 40.65
GOOD
  ROE Change Average (%) / Sector
-21,533.14 / 2,109.80
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 8%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 4.17
Chi tiết đăng ký
X
  Analyze Date 2026-06-06 09:08:48
  Symbol KLRA
  Name KAILERA THERAPEUTICS, INC. COMMON STOCK
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 129.57 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 2,899.68 / 8,857.28
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 180 Third Avenue, Waltham, MA, United States, 02451

Phone: 781 317 0290

Website: https://www.kailera.com

Employees: 145

Sector: Healthcare >> Biotechnology

Description: Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.

ME vs SECTOR Healthcare >> Biotechnology

KLRA (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
KLRA
KLRA
USD 19.37 (-7.72%)
+ Watch + Port Chart